Published source snapshot
Omega 3-DHA
Womens Choice Pharmaceuticals · US label facts
Label IDlbl_dsld_37269_a2c6fadb0653061c
Serving size1 Softgel(s)
Serving formSoftgel(s)
Retrieved
Scope: source-market status describes the source record, not live availability. Quantities below are label facts and deterministic arithmetic, not a product recommendation.
Original facts and normalized results
| Ingredient | Original label quantity | Requested normalization | Measurement object |
|---|---|---|---|
| DHA (Docosahexaenoic Acid) DSLD row path: root.0; DSLD ingredientId: 285076 | 120 mg | 120 mg / as_labeled | Doconexent |
| Eicosapentaenoic Acid DSLD row path: root.1; DSLD ingredientId: 285941 | 180 mg | 180 mg / as_labeled | Icosapent |
| Vitamin E DSLD row path: root.2; DSLD ingredientId: 280328 | 2 IU | 2 IU / as_labeled | D-Alpha-Tocopherol |
| Gelatin Listed as an other ingredient; no amount is supplied. DSLD ingredientId: 27352. | Not stated | missing_quantity | Gelatin |
| Glycerol Listed as an other ingredient; no amount is supplied. DSLD ingredientId: 3985. | Not stated | missing_quantity | Glycerin |
| Water Listed as an other ingredient; no amount is supplied. DSLD ingredientId: 4737. | Not stated | missing_quantity | Water |
Label statements
These are explicitly classified as label claims. They are not converted into platform-endorsed scientific conclusions.
- label_claim Precautions re: Pregnant or Nursing or Prescription Medications: If you are pregnant, nursing, or taking any medications consult your doctor before use.
- label_claim Precautions re: All Other: Contraindications: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients. Warnings: Ingestion of more than 3 grams of omega-fatty acids per day has been shown to have potential antithrombotic effects, including increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis.
- label_claim Formulation re: Does NOT Contain: Gluten Free
- label_claim Formula re: Type: Indications and Usage: Nestabs ABC is indicated to provide vitamin/mineral and omega-3 fatty acid supplementation to women throughout pregnancy, during the postnatal for both lactating and nonlactating mothers. Nestabs DHA is also beneficial in improving the nutritional status of women prior to conception.
- label_claim General Statements: All Other Content: How Supplied: Nestabs ABC tablets for oral administration are supplied as six child-resistant blister cards containing 5 tablets and 5 softgel capsules each (NDC# 50967-309-30).
- label_claim General Statements: All Other Content: Descripton: Nestabs ABC combination tablet-capsule for oral administration is a light green capsule-shaped film coated tablet with a pleasant sweet flavor with WC003 imprinted on one side of the tablet and a light amber soft gel capsule omega-3 fatty acid containing both DHA and EPA.
- label_claim FDA Statement of Identity: Prenatal Multi-vitamin/Mineral Supplement
- label_claim Precautions re: Children: Not intended for use by persons under the age of 18.
- label_claim Precautions re: All Other: Discontinue use and consult your doctor if any adverse reactions occur.
- label_claim Suggested/Recommended/Usage/Directions: Dosage and Administration: Nestabs ABC - One tablet and one soft gel capsule daily or as directed by a physician.
Ingredient references
Reference pages provide verified source mappings. Unless a real review record exists, they remain reference-only with no medical summary or evidence grade.
Source and version
- Original record
- NIH ODS DSLD label 37269
- Local snapshot
- snap_dsld_37269_a2c6fadb0653061cc4182274
- Content hash
a2c6fadb0653061cc418227494c8a6f9116776714293fcb62919ff3b4c67cb1a- Source version
- Not stated
Limitations
- This record reports label facts from a US-market source snapshot, not current inventory or product safety.
- Label quantity comparisons do not establish absorption, efficacy, safety, or clinical equivalence.